1. Home
  2. ARL vs DCTH Comparison

ARL vs DCTH Comparison

Compare ARL & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Realty Investors Inc.

ARL

American Realty Investors Inc.

N/A

Current Price

$16.10

Market Cap

245.7M

Sector

Real Estate

ML Signal

N/A

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$9.99

Market Cap

289.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARL
DCTH
Founded
1999
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
245.7M
289.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
ARL
DCTH
Price
$16.10
$9.99
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$22.60
AVG Volume (30 Days)
1.6K
748.8K
Earning Date
11-06-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.36
0.03
Revenue
$49,060,000.00
$79,603,000.00
Revenue This Year
N/A
$131.97
Revenue Next Year
N/A
$38.84
P/E Ratio
$42.90
$300.53
Revenue Growth
N/A
251.54
52 Week Low
$9.43
$8.12
52 Week High
$17.00
$18.23

Technical Indicators

Market Signals
Indicator
ARL
DCTH
Relative Strength Index (RSI) 55.21 56.07
Support Level $15.26 $9.59
Resistance Level $15.98 $10.65
Average True Range (ATR) 0.22 0.45
MACD 0.05 0.13
Stochastic Oscillator 65.71 63.00

Price Performance

Historical Comparison
ARL
DCTH

About ARL American Realty Investors Inc.

American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: